India to Turkmenistan: Raltegravir Export Trade Route

The India to Turkmenistan Raltegravir corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $115.8K USD. The route is dominated by R R PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's raltegravir manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $57.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with raltegravir's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 16.4%, placing it at rank #5 among India's top raltegravir export destinations globally.

On the import side, key buyers of Indian raltegravir in Turkmenistan include DIRECTORATE OF CENTERS FOR INFECTIOUS DISEASES HOSPITAL C CHOGANLY. DIRECTORATE OF CENTERS FOR INFECTIOUS DISEASES HOSPITAL C CHOGANLY is the single largest importer with 2 shipments valued at $115.8K USD.

India's raltegravir exports to Turkmenistan are driven primarily by a handful of large-scale manufacturers. R R PHARMACEUTICALS PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Turkmenistan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — R R PHARMACEUTICALS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $57.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as raltegravir dispersible tabs. 100 mg p:1x60 b.no. rim-005 m:10/23e:9/25, suggesting that buyers in Turkmenistan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, DIRECTORATE OF CENTERS FOR INFECTIOUS DISEASES HOSPITAL C CHOGANLY is the largest importer with 2 shipments worth $115.8K USD — representing 100% of all raltegravir imports from India on this route.